SAGE
SAGE Therapeutics Inc
Price:  
11.80 
USD
Volume:  
737,025.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SAGE Relative Valuation

-2574.3%
Upside

As of 2024-07-15, the Relative Valuation of SAGE Therapeutics Inc (SAGE) is (291.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.80 USD, the upside of SAGE Therapeutics Inc based on Relative Valuation is -2574.3%.

The range of the Relative Valuation is (263.33) - (261.66) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 31.5x - 47.1x 39.3x
Forward P/E multiples 29.8x - 31.3x 30.6x
Fair Price (263.33) - (261.66) (291.96)
Upside -2331.6% - -2317.5% -2574.3%
11.80 USD
Stock Price
(291.96) USD
Fair Price

SAGE Relative Valuation - Historical P/E Data

Date P/E
2024-07-15 -1.41
2024-07-12 -1.41
2024-07-11 -1.40
2024-07-10 -1.32
2024-07-09 -1.37
2024-07-08 -1.31
2024-07-05 -1.29
2024-07-03 -1.27
2024-07-02 -1.29
2024-07-01 -1.32
2024-06-28 -1.30
2024-06-27 -1.28
2024-06-26 -1.30
2024-06-25 -1.30
2024-06-24 -1.38
2024-06-21 -1.33
2024-06-20 -1.28
2024-06-18 -1.29
2024-06-17 -1.35
2024-06-14 -1.44
2024-06-13 -1.38
2024-06-12 -1.30
2024-06-11 -1.27
2024-06-10 -1.30
2024-06-07 -1.27
2024-06-06 -1.29
2024-06-05 -1.31
2024-06-04 -1.28
2024-06-03 -1.33
2024-05-31 -1.33
2024-05-30 -1.38
2024-05-29 -1.30
2024-05-28 -1.43
2024-05-24 -1.41
2024-05-23 -1.35
2024-05-22 -1.45
2024-05-21 -1.44
2024-05-20 -1.34
2024-05-17 -1.40
2024-05-16 -1.44
2024-05-15 -1.40
2024-05-14 -1.43
2024-05-13 -1.46
2024-05-10 -1.42
2024-05-09 -1.48
2024-05-08 -1.48
2024-05-07 -1.55
2024-05-06 -1.58
2024-05-03 -1.67
2024-05-02 -1.57